CRA Insights: Life Sciences: April 2015

CRA Insights: Life Sciences: April 2015

Life Sciences

The drug pricing debate is top of mind with manufacturers, payers, governments, patients, and the medical professionals who treat them. In this issue of CRA Insights: Life Sciences we examine some of these issues.

Download PDF